Cite
Xu J, Yang X, Huang C, et al. A Novel Risk-Stratification Models of the High-Flow Nasal Cannula Therapy in COVID-19 Patients With Hypoxemic Respiratory Failure. Front Med (Lausanne). 2020;7:607821doi: 10.3389/fmed.2020.607821.
Xu, J., Yang, X., Huang, C., Zou, X., Zhou, T., Pan, S., Yang, L., Wu, Y., Ouyang, Y., Wang, Y., Xu, D., Zhao, X., Shu, H., Jiang, Y., Xiong, W., Ren, L., Liu, H., Yuan, Y., Qi, H., Fu, S., Chen, D., Zhang, D., Yuan, S., & Shang, Y. (2020). A Novel Risk-Stratification Models of the High-Flow Nasal Cannula Therapy in COVID-19 Patients With Hypoxemic Respiratory Failure. Frontiers in medicine, 7607821. https://doi.org/10.3389/fmed.2020.607821
Xu, Jiqian, et al. "A Novel Risk-Stratification Models of the High-Flow Nasal Cannula Therapy in COVID-19 Patients With Hypoxemic Respiratory Failure." Frontiers in medicine vol. 7 (2020): 607821. doi: https://doi.org/10.3389/fmed.2020.607821
Xu J, Yang X, Huang C, Zou X, Zhou T, Pan S, Yang L, Wu Y, Ouyang Y, Wang Y, Xu D, Zhao X, Shu H, Jiang Y, Xiong W, Ren L, Liu H, Yuan Y, Qi H, Fu S, Chen D, Zhang D, Yuan S, Shang Y. A Novel Risk-Stratification Models of the High-Flow Nasal Cannula Therapy in COVID-19 Patients With Hypoxemic Respiratory Failure. Front Med (Lausanne). 2020 Dec 08;7:607821. doi: 10.3389/fmed.2020.607821. eCollection 2020. PMID: 33425951; PMCID: PMC7793962.
Copy
Download .nbib